Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Status:
Recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The DELIVER-MS study seeks to answer the question: Does early treatment with highly effective
DMT improve the prognosis for people with MS? This is an area of significant controversy and
no data currently exist to guide treatment choices for patients and clinicians. The study
results will help guide overall treatment philosophy and will be applicable not only to a
wide range of existing therapies but also to new therapies, meeting a significant unmet need
in patient decision making and aiding the decision for medication approval by third parties.